GDATP awarded SAFETY Act certification for biological detection system

Published 21 November 2005

Charlotte, North Carolina-based General Dynamics Armament and Technical Products (GDATP), a business unit of General Dynamics (NYSE: GD), says its Joint Biological Point Detection System has earned designation and certification as a “qualified anti-terrorism technology” under the Support Anti-Terrorism by Fostering Effective Technologies Act (SAFETY Act). The SAFETY Act was signed into law as a provision of the Homeland Security Act of 2002, and its purpose is to promote the development of effective antiterrorism products, services, and technologies by protecting certified companies and their customers from liability in the event a terrorist act occurs and their product has unforeseen side effects. The act calls on DHS to examine each application for certification based on risk-benefit analysis.

The Joint Biological Point Detection System (JBPDS) is a self-powered biological warfare agent detection and identification instrument suite which detects and identifies biological warfare agents such as airborne viruses, bacteria, and toxins. The JBPDS is available in man-portable, shelter-based, ship-based, and trailer-mounted variants, and meets all the environmental, vibration, and shock requirements of its intended platforms. The JBPDS is a Joint Services program and is configured to meet the operational requirements of the U.S. uniformed services.

-read more in this company news release